A M Sadowska

Summary

Affiliation: University of Antwerp
Country: Belgium

Publications

  1. ncbi Use of ICAM-1 antibodies and antisense oligonucleotides to inhibit transmigration of neutrophils
    A M Sadowska
    Department of Respiratory Medicine, Antwerp Metabolic Research Unit, University of Antwerp UIA, Universiteitsplein 1, 2610 Antwerpen Wilrijk, Belgium
    Inflamm Res 53:143-9. 2004
  2. ncbi The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant
    A M Sadowska
    Department of Respiratory Medicine, University of Antwerp, Antwerpen, Belgium
    Respir Med 99:241-9. 2005
  3. ncbi Inhibition of in vitro neutrophil migration through a bilayer of endothelial and epithelial cells using beta2-agonists: concomitant effects on IL-8 and elastase secretion and impact of glucocorticosteroids
    A M Sadowska
    Department of Respiratory Medicine, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    Pulm Pharmacol Ther 18:354-62. 2005
  4. ncbi Effect of N-acetylcysteine on neutrophil activation markers in healthy volunteers: in vivo and in vitro study
    Anna M Sadowska
    Antwerp Metabolic Research Unit, Department of Respiratory Medicine, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    Pharmacol Res 53:216-25. 2006
  5. ncbi Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review
    A M Sadowska
    Department of Respiratory Medicine, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    Pulm Pharmacol Ther 20:9-22. 2007
  6. ncbi Systemic antioxidant defences during acute exacerbation of chronic obstructive pulmonary disease
    Anna M Sadowska
    Department of Pulmonary Medicine, University of Antwerp, Antwerp, Belgium
    Respirology 11:741-7. 2006
  7. ncbi Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication?
    A M Sadowska
    Department of Pulmonary Medicine, University of Antwerp, 2610 Antwerp, Belgium
    Steroids 72:1-6. 2007
  8. ncbi Role of N-acetylcysteine in the management of COPD
    Anna M Sadowska
    Department of Pulmonary Medicine, University of Antwerp, Antwerp, Belgium
    Int J Chron Obstruct Pulmon Dis 1:425-34. 2006
  9. ncbi Antioxidant defence during cardiopulmonary bypass surgery
    Chris R Luyten
    Department of Respiratory Medicine, University of Antwerp, Universiteitsplein 1, B-2610 Antwerpen-Wilrijk, Belgium
    Eur J Cardiothorac Surg 27:611-6. 2005

Collaborators

Detail Information

Publications9

  1. ncbi Use of ICAM-1 antibodies and antisense oligonucleotides to inhibit transmigration of neutrophils
    A M Sadowska
    Department of Respiratory Medicine, Antwerp Metabolic Research Unit, University of Antwerp UIA, Universiteitsplein 1, 2610 Antwerpen Wilrijk, Belgium
    Inflamm Res 53:143-9. 2004
    ..The increase in adhesion molecule expression during the initial phase of inflammation leads to transmigration of neutrophils. Inhibition of this transmigration could decrease inflammatory response and tissue damage...
  2. ncbi The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant
    A M Sadowska
    Department of Respiratory Medicine, University of Antwerp, Antwerpen, Belgium
    Respir Med 99:241-9. 2005
    ..This study aimed to characterise the relationship between oxidative stress and inflammatory components in induced sputum and blood...
  3. ncbi Inhibition of in vitro neutrophil migration through a bilayer of endothelial and epithelial cells using beta2-agonists: concomitant effects on IL-8 and elastase secretion and impact of glucocorticosteroids
    A M Sadowska
    Department of Respiratory Medicine, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    Pulm Pharmacol Ther 18:354-62. 2005
    ..In this study we aimed to investigate the anti-inflammatory effect of combination therapy in vitro...
  4. ncbi Effect of N-acetylcysteine on neutrophil activation markers in healthy volunteers: in vivo and in vitro study
    Anna M Sadowska
    Antwerp Metabolic Research Unit, Department of Respiratory Medicine, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    Pharmacol Res 53:216-25. 2006
    ..We wished to evaluate both in vivo and in vitro whether N-acetylcysteine (NAC) has an effect on the response of activated neutrophils...
  5. ncbi Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review
    A M Sadowska
    Department of Respiratory Medicine, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium
    Pulm Pharmacol Ther 20:9-22. 2007
    ....
  6. ncbi Systemic antioxidant defences during acute exacerbation of chronic obstructive pulmonary disease
    Anna M Sadowska
    Department of Pulmonary Medicine, University of Antwerp, Antwerp, Belgium
    Respirology 11:741-7. 2006
    ..This study aims to examine the extent and time-course of antioxidant defence in patients with an acute exacerbation of COPD in comparison with stable patients...
  7. ncbi Glucocorticosteroids as antioxidants in treatment of asthma and COPD. New application for an old medication?
    A M Sadowska
    Department of Pulmonary Medicine, University of Antwerp, 2610 Antwerp, Belgium
    Steroids 72:1-6. 2007
    ..This review summarizes the effects of steroids on the antioxidant enzymes activity in vitro and in vivo in relation to asthma and COPD...
  8. ncbi Role of N-acetylcysteine in the management of COPD
    Anna M Sadowska
    Department of Pulmonary Medicine, University of Antwerp, Antwerp, Belgium
    Int J Chron Obstruct Pulmon Dis 1:425-34. 2006
    ....
  9. ncbi Antioxidant defence during cardiopulmonary bypass surgery
    Chris R Luyten
    Department of Respiratory Medicine, University of Antwerp, Universiteitsplein 1, B-2610 Antwerpen-Wilrijk, Belgium
    Eur J Cardiothorac Surg 27:611-6. 2005
    ..The human body has a strong innate oxidative defence screen, which is probably not sufficient to fully compensate for the total amount of oxidative damage...